Internal Server Error

About Elev8

Elev8 is a venture capital firm founded in 2018. It is primarily based out of Singapore, Singapore. As of Feb 2026, Elev8 is an active investor, having invested in 28 companies, with 3 new investments in the last 12 months. It primarily invests in Seed round in Singapore based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to Auto Tech and High Tech. Most recently it participated in the $***** Series F round of Idfy Overall, Elev8 portfolio has seen 4 acquisitions including key companies like Preteckt, Civil Maps and Jumper.ai. A lot of funds co-invest with Elev8, with names like SEEDS Capital sharing a substantial percentage of its portfolio. Elev8 has team of 5 people including 2 partners.
Key Metrics
Portfolio Count
Portfolio Locations
Rounds of Entry
Seed, Series A & 1 more
Portfolio Acquisitions
Portfolio Soonicorns
Deals in last 12 months

Elev8's List of Top Investments

Elev8 has a portfolio of 28 companies. Their most notable investments are in Equatorial Space and UNL.Their portfolio spans across Singapore, United States, India and 4 more locations. They have invested in Enterprise Applications, Auto Tech, High Tech and 16 other sectors, across stages such as Seed, Series A  and 1 more. Here is the list of top investments by Elev8:

1. Idfy

Provider of a platform for identity verification and risk management. The platform offers tools for customer and workforce governance throughout their lifecycle. It focuses on frictionless onboarding, verifiable identities, and faster revenue generation. The platform aims to reduce onboarding friction, prevent fraud, and accelerate time-to-revenue. It helps detect and mitigate risk in real time, reducing financial and operational losses. The platform also transforms compliance into a growth engine through centralized automation.

Key facts about Idfy

  • Founded Year: 2011
  • Location: Mumbai (India)
  • Annual Revenue: ₹100 - ₹500 Cr as on Mar 31, 2025
  • Valuation: $*****
  • Stage: Series F
  • Total Funding till date: $85.7M
  • Employee Count: 697 as on Aug 31, 2025
  • Investors: Trifecta Capital, NB Ventures and 41 Others
  • Latest Funding Round: Series F, Jun 22, 2026, $*****
  • Highlight: Editors' Pick
Provider of wearable devices to track respiratory conditions. It offers a wearable stethoscope that can continuously monitor the condition of asthma patients using its proprietary algorithms. It can be attached to the body to measure various parameters like heart rate, breathing rate, wheezing, and coughing. Its features include dashboard view and automated periodical reports. It also offers wearable patches for kids to track their health trends.

Key facts about Aevice Health

Non-invasive algorithm-based diagnostics. The company uses machine learning to target specific physiological and pathological processes, in order to assess subclinical biomarker profiles in plasma for diagnosis and prognosis of disease pathologies. Applications under investigation include cardiometabolic diseases, idiopathic pulmonary fibrosis, and chronic renal diseases.

Key facts about Fibronostics

  • Founded Year: 2015
  • Location: Orlando (United States)
  • Stage: Series A
  • Total Funding till date: $14.5M
  • Employee Count: 27 as on Sep 30, 2026
  • Investors: AT Capital, Elev8 and 1 Other
  • Latest Funding Round: Series A, Jun 15, 2022, $*****
  • Highlight: Editors' Pick
Developer of AI and automation solutions for yield forecasting and pollination. The company provides data-driven insights and scalable technology for open-field and protected cropping systems. Solutions include forecasting yield and harvest readiness, plus autonomous pollination. The contactless pollination method uses aerodynamically controlled pollination, designed to optimally vibrate flower clusters.

Key facts about Polybee Systems

  • Founded Year: 2019
  • Location: Singapore (Singapore)
  • Stage: Seed
  • Total Funding till date: $4.3M
  • Employee Count: 20 as on Aug 31, 2026
  • Investors: SEEDS Capital, Elev8 and 2 Others
  • Latest Funding Round: Seed, Feb 09, 2026, $*****
Mesh Bio provides software for chronic disease management through predictive analytics. The software translates clinical data and numbers into actionable insights that help patients better manage their health, lifestyle, and disease risks. The software provides clinical decision support for healthcare professionals

Key facts about Mesh Bio

  • Founded Year: 2018
  • Location: Singapore (Singapore)
  • Annual Revenue: SGD 0 - 1M as on Dec 31, 2022
  • Stage: Series A
  • Total Funding till date: $6.5M
  • Employee Count: 28 as on Sep 30, 2026
  • Investors: SEEDS Capital, YL Ventures and 17 Others
  • Latest Funding Round: Series A, Oct 12, 2023, $*****
  • Highlight: Editors' Pick

Elev8's Investments by Stage

Elev8 has made 12 investments in Seed stage with an average round size of $2.65M, 3 investments in Series A stage with an average round size of $5.5M and 1 investment in Series F stage with an average round size of $24.3M.
Here are Elev8's investments by stage:
Stage of entry
No. of Investments
Seed
12
Series A
3
Series F
1
Breakdown of Elev8's investments by stage of entrySeed (12)Series A (3)
Note: We have considered here, only first round of investments

Elev8's Investments by Sector

Elev8 has a diverse portfolio, with companies operating in the Enterprise Applications, High Tech, HealthTech, Life Sciences and Aerospace, Maritime and Defense Tech. Notably, it has invested in 25 Enterprise (B2B) companies, 25 Tech companies, 18 Software companies and at least 11 companies focusing on Tech hardware.
Here are Elev8's investments by sector:
Sector
No. of Investments
Enterprise Applications
9
High Tech
6
HealthTech
5
Life Sciences
4
Aerospace, Maritime and Defense Tech
3
Others
16
Breakdown of Elev8's investments by sectorsEnterprise Applic... (9)High Tech (6)
Note: We have considered here, only first round of investments

Elev8's Investments by Geography

Elev8 has made most investments in Singapore (11), followed by United States where it has made 2 investments.
Here are Elev8's investments by geography:
Country
No. of Investments
Singapore
11
United States
2
Germany
1
India
1
Indonesia
1
Breakdown of Elev8's investments by countriesSingapore (11)United States (2)
Note: We have considered here, only first round of investments

Elev8's recent investments

Elev8 has made 2 investments in 2026 so far - Idfy and Polybee Systems.
Here are the most recent investments by Elev8:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Feb 13, 2026
India
Series F
5073
Feb 09, 2026
Singapore
Seed
6045
  [+2]
Oct 20, 2025
Singapore
Seed
6441
Jul 22, 2025
Germany
Series A
9028
Jan 18, 2025
Singapore
Seed
1001

Acquired companies in Elev8's Portfolio

4 companies from Elev8's portfolio have been acquired. The most recent acquisition was Preteckt in Feb 2025 by Diesel Laptops for $*****.
Here are Elev8's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Feb 10, 2025
-
-
2560
Jan 04, 2023
-
-
3447
Jul 26, 2022
-
-
6302
Oct 19, 2021
-
-
6237

Team profile of Elev8

Elev8 has a team of 5 members including 2 Partners. Elev8's team sits on the board of 4 companies.

Co-investors of Elev8

Over the past 7 years, 84 investors have co-invested in Elev8's portfolio companies. This includes funds and angels.

  • Invested before Elev8: East Ventures, Blume Venture and 29 others have invested in rounds before Elev8. There are 2 companies where East Ventures has invested before Elev8 and 1 company where Blume Venture has invested before Elev8.
  • Top Co-investors of Elev8: 34 investors entered a company along with Elev8. These include investors like SEEDS Capital (4 companies).
  • Invested after Elev8: A total of 19 investors have invested in Elev8's portfolio after their investments. Top Investors include SEEDS Capital (3 companies), State Farm (2 companies) and East Ventures (1 company).

Recent News related to Elev8

•
Elev8.vc invests $30m in deep tech startups with global ambitionSingapore Business Review•Jan 28, 2025•Elev8
•
Singapore's BluMaiden Secures Major Funds for AI Drug Discovery ExpansionCEO Insights Asia All Rights Reserved•Jul 23, 2024•BluMaiden, Elev8, SEEDS Capital
View all news related to Elev8

FAQs about Elev8

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford